Nifty
Sensex
:
:
26013.45
84950.95
103.40 (0.40%)
388.17 (0.46%)

Pharmaceuticals & Drugs

Rating :
56/99

BSE: 506128 | NSE: Not Listed

129.10
14-Nov-2025
  • Open
  • High
  • Low
  • Previous Close
  •  130
  •  131
  •  129.1
  •  129.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  166
  •  21581
  •  131
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 148.28
  • 13.72
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 206.24
  • N/A
  • 1.72

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.30%
  • 0.50%
  • 24.93%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.27%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.18
  • 15.83
  • 3.85

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.38
  • 21.89
  • 3.09

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.51
  • -
  • 10.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.72
  • 11.24
  • 11.22

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.26
  • 1.49
  • 1.63

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.15
  • 7.50
  • 6.80

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
53.38
50.12
6.50%
49.04
46.37
5.76%
40.22
50.99
-21.12%
48.36
42.61
13.49%
Expenses
45.94
41.50
10.70%
42.41
40.57
4.54%
35.94
45.02
-20.17%
41.12
37.33
10.15%
EBITDA
7.44
8.62
-13.69%
6.63
5.80
14.31%
4.27
5.97
-28.48%
7.24
5.29
36.86%
EBIDTM
13.93%
17.19%
13.52%
12.50%
10.63%
11.71%
14.97%
12.40%
Other Income
0.19
0.11
72.73%
0.43
0.25
72.00%
0.19
0.10
90.00%
0.95
0.22
331.82%
Interest
1.22
1.50
-18.67%
1.28
1.41
-9.22%
1.23
1.35
-8.89%
1.39
1.43
-2.80%
Depreciation
1.94
1.83
6.01%
1.83
1.85
-1.08%
1.79
1.78
0.56%
1.94
1.74
11.49%
PBT
4.46
5.40
-17.41%
3.95
2.79
41.58%
1.45
2.94
-50.68%
4.87
2.34
108.12%
Tax
1.18
1.42
-16.90%
1.03
0.55
87.27%
0.24
0.76
-68.42%
1.46
0.47
210.64%
PAT
3.28
3.99
-17.79%
2.92
2.25
29.78%
1.21
2.18
-44.50%
3.41
1.87
82.35%
PATM
6.14%
7.95%
5.96%
4.84%
3.02%
4.27%
7.06%
4.39%
EPS
2.85
3.47
-17.87%
2.54
1.95
30.26%
1.05
1.89
-44.44%
2.97
1.63
82.21%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
191.00
187.74
188.71
167.61
163.03
90.06
95.31
108.78
105.50
94.81
71.18
Net Sales Growth
0.48%
-0.51%
12.59%
2.81%
81.02%
-5.51%
-12.38%
3.11%
11.28%
33.20%
 
Cost Of Goods Sold
102.49
96.00
102.81
88.82
89.64
41.76
45.28
52.71
54.90
49.94
37.80
Gross Profit
88.51
91.74
85.90
78.79
73.39
48.30
50.04
56.07
50.60
44.87
33.38
GP Margin
46.34%
48.87%
45.52%
47.01%
45.02%
53.63%
52.50%
51.54%
47.96%
47.33%
46.90%
Total Expenditure
165.41
160.97
165.17
144.62
140.00
80.11
88.89
98.56
95.76
82.41
61.21
Power & Fuel Cost
-
6.06
6.37
5.37
5.24
4.29
4.12
3.13
2.99
3.27
2.11
% Of Sales
-
3.23%
3.38%
3.20%
3.21%
4.76%
4.32%
2.88%
2.83%
3.45%
2.96%
Employee Cost
-
24.43
23.72
20.05
17.43
13.68
14.08
13.06
11.68
9.22
7.46
% Of Sales
-
13.01%
12.57%
11.96%
10.69%
15.19%
14.77%
12.01%
11.07%
9.72%
10.48%
Manufacturing Exp.
-
24.20
24.04
21.73
19.86
13.97
17.03
15.53
13.96
14.24
9.04
% Of Sales
-
12.89%
12.74%
12.96%
12.18%
15.51%
17.87%
14.28%
13.23%
15.02%
12.70%
General & Admin Exp.
-
8.26
6.48
6.32
5.06
4.69
5.80
5.99
6.29
4.36
3.27
% Of Sales
-
4.40%
3.43%
3.77%
3.10%
5.21%
6.09%
5.51%
5.96%
4.60%
4.59%
Selling & Distn. Exp.
-
1.66
1.72
2.00
2.20
1.36
1.38
6.80
4.20
0.98
0.95
% Of Sales
-
0.88%
0.91%
1.19%
1.35%
1.51%
1.45%
6.25%
3.98%
1.03%
1.33%
Miscellaneous Exp.
-
0.36
0.02
0.32
0.58
0.36
1.20
1.34
1.74
0.41
0.95
% Of Sales
-
0.19%
0.01%
0.19%
0.36%
0.40%
1.26%
1.23%
1.65%
0.43%
0.80%
EBITDA
25.58
26.77
23.54
22.99
23.03
9.95
6.42
10.22
9.74
12.40
9.97
EBITDA Margin
13.39%
14.26%
12.47%
13.72%
14.13%
11.05%
6.74%
9.40%
9.23%
13.08%
14.01%
Other Income
1.76
1.68
0.82
0.77
0.33
0.21
0.67
2.11
1.34
0.99
0.70
Interest
5.12
5.39
5.35
4.95
5.23
5.08
4.60
3.89
4.32
4.92
4.29
Depreciation
7.50
7.38
6.96
6.53
5.87
5.16
4.46
3.82
3.74
3.75
2.90
PBT
14.73
15.67
12.05
12.28
12.26
-0.08
-1.97
4.62
3.02
4.71
3.48
Tax
3.91
4.13
2.42
3.65
4.01
0.28
0.95
1.31
1.97
1.02
0.97
Tax Rate
26.54%
26.36%
20.08%
29.72%
32.71%
-350.00%
-48.22%
28.35%
65.23%
21.66%
27.87%
PAT
10.82
11.52
9.60
8.62
8.24
-0.36
-2.92
3.30
1.06
3.68
2.50
PAT before Minority Interest
10.79
11.54
9.62
8.63
8.26
-0.36
-2.92
3.31
1.06
3.69
2.51
Minority Interest
-0.03
-0.02
-0.02
-0.01
-0.02
0.00
0.00
-0.01
0.00
-0.01
-0.01
PAT Margin
5.66%
6.14%
5.09%
5.14%
5.05%
-0.40%
-3.06%
3.03%
1.00%
3.88%
3.51%
PAT Growth
5.15%
20.00%
11.37%
4.61%
-
-
-
211.32%
-71.20%
47.20%
 
EPS
9.41
10.02
8.35
7.50
7.17
-0.31
-2.54
2.87
0.92
3.20
2.17

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
83.10
71.57
62.15
48.19
32.54
32.80
35.73
32.51
31.37
27.64
Share Capital
11.49
11.49
11.49
9.81
8.50
8.50
8.50
8.50
8.50
8.50
Total Reserves
71.61
60.09
50.67
36.55
24.04
24.29
27.23
24.01
22.86
19.14
Non-Current Liabilities
32.24
35.24
19.77
24.21
19.26
21.83
22.58
17.60
17.65
22.81
Secured Loans
17.99
21.05
12.02
17.41
13.94
19.12
16.19
11.70
12.57
13.72
Unsecured Loans
0.00
0.00
0.00
0.00
0.03
0.03
5.39
5.00
4.51
8.59
Long Term Provisions
0.63
0.61
0.51
0.47
0.26
0.27
0.29
0.23
0.38
0.00
Current Liabilities
74.33
83.33
63.04
80.98
54.37
52.46
36.29
37.19
36.45
28.90
Trade Payables
21.35
23.68
14.76
22.08
6.23
10.86
7.26
7.68
7.67
3.09
Other Current Liabilities
16.90
16.36
14.43
15.56
11.65
13.45
13.31
14.47
13.12
11.27
Short Term Borrowings
35.96
43.21
33.27
42.70
36.43
28.11
15.69
15.03
15.65
13.05
Short Term Provisions
0.12
0.07
0.58
0.64
0.06
0.03
0.04
0.02
0.01
1.50
Total Liabilities
189.81
190.26
145.07
153.47
106.25
107.16
94.68
87.37
85.53
79.40
Net Block
88.26
89.48
76.81
71.95
59.66
57.68
51.06
43.70
47.32
37.85
Gross Block
128.74
126.62
108.00
97.25
79.40
72.73
61.65
50.47
51.07
58.88
Accumulated Depreciation
40.48
37.14
31.20
25.30
19.73
15.05
10.59
6.77
3.75
21.03
Non Current Assets
121.48
113.33
84.01
78.70
67.02
61.55
57.79
50.91
54.66
48.84
Capital Work in Progress
29.44
20.61
2.33
3.34
4.91
2.91
0.14
0.00
0.00
2.44
Non Current Investment
0.16
0.16
0.16
0.22
0.22
0.22
0.21
0.23
0.34
0.91
Long Term Loans & Adv.
3.62
3.08
4.71
3.14
2.18
0.73
6.37
6.98
7.00
7.64
Other Non Current Assets
0.00
0.00
0.00
0.05
0.04
0.00
0.00
0.00
0.00
0.00
Current Assets
64.78
73.31
57.32
71.03
39.24
45.61
36.90
36.46
30.87
30.57
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
25.77
29.93
21.69
19.93
10.79
11.15
8.47
7.67
7.94
6.63
Sundry Debtors
30.76
32.56
27.89
38.08
16.71
23.08
19.18
18.66
18.66
19.42
Cash & Bank
2.68
1.88
2.78
5.78
1.27
1.30
0.60
1.61
1.13
0.38
Other Current Assets
5.56
0.00
0.00
0.00
10.48
10.08
8.64
8.52
3.14
4.14
Short Term Loans & Adv.
5.56
8.94
4.96
7.24
6.57
6.13
4.73
4.51
3.14
4.14
Net Current Assets
-9.56
-10.02
-5.72
-9.95
-15.13
-6.84
0.61
-0.73
-5.58
1.66
Total Assets
186.26
186.64
141.33
149.73
106.26
107.16
94.69
87.37
85.53
79.41

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
32.30
15.88
20.91
8.55
6.31
8.75
8.72
12.88
16.05
3.49
PBT
15.67
12.05
12.28
12.26
-0.08
-1.97
4.62
3.02
4.71
3.48
Adjustment
12.84
11.86
11.58
11.05
10.23
8.97
7.70
9.60
8.78
3.04
Changes in Working Capital
6.53
-5.40
-0.09
-14.53
-3.08
2.81
-2.21
0.91
3.91
-1.90
Cash after chg. in Working capital
35.04
18.52
23.77
8.78
7.07
9.82
10.12
13.53
17.40
4.62
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.74
-2.64
-2.86
-0.24
-0.76
-1.07
-1.40
-0.65
-1.35
-1.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-16.39
-31.52
-9.92
-16.50
-6.56
-13.33
-11.15
-5.18
-10.22
-6.18
Net Fixed Assets
0.00
-0.12
-0.06
0.00
0.00
0.00
0.00
6.02
9.34
0.32
Net Investments
0.00
0.00
0.04
0.00
0.00
0.00
-0.05
0.11
0.58
0.00
Others
-16.39
-31.40
-9.90
-16.50
-6.56
-13.33
-11.10
-11.31
-20.14
-6.50
Cash from Financing Activity
-15.82
14.82
-14.07
12.13
0.05
5.03
1.42
-7.18
-5.45
0.72
Net Cash Inflow / Outflow
0.09
-0.82
-3.08
4.18
-0.21
0.44
-1.01
0.53
0.38
-1.97
Opening Cash & Equivalents
0.46
1.28
4.36
0.18
0.39
-0.05
0.96
0.43
0.05
2.36
Closing Cash & Equivalent
0.55
0.46
1.28
4.36
0.18
0.39
-0.05
0.96
0.43
0.38

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
72.35
62.32
54.11
47.24
38.26
38.56
42.01
38.23
36.88
32.50
ROA
6.07%
5.74%
5.78%
6.36%
-0.34%
-2.89%
3.63%
1.22%
4.48%
3.09%
ROE
14.92%
14.39%
15.91%
20.93%
-1.11%
-8.51%
9.69%
3.31%
12.51%
9.50%
ROCE
14.71%
13.61%
15.20%
17.34%
5.83%
3.27%
11.59%
10.49%
13.73%
11.47%
Fixed Asset Turnover
1.47
1.61
1.63
1.85
1.18
1.42
1.94
2.08
1.72
1.26
Receivable days
61.56
58.46
71.83
61.33
80.64
80.93
63.50
64.56
73.29
109.98
Inventory Days
54.14
49.92
45.31
34.39
44.46
37.57
27.08
27.01
28.05
35.01
Payable days
85.60
68.24
75.70
57.63
74.68
73.02
28.47
30.58
24.08
38.03
Cash Conversion Cycle
30.10
40.14
41.44
38.08
50.42
45.48
62.11
60.99
77.26
106.96
Total Debt/Equity
0.73
0.99
0.82
1.41
1.71
1.54
1.17
1.13
1.26
1.51
Interest Cover
3.91
3.25
3.48
3.34
0.98
0.57
2.19
1.70
1.96
1.81

Top Investors:

News Update:


  • Parnax Lab - Quarterly Results
    13th Aug 2025, 17:07 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.